Assessing the influence of warnings with testimonies from former smokers on smoking and quitting behaviour

Assessing the influence of warnings with testimonies from former smokers on smoking and quitting behaviour

Cigarette pack warnings are broadly used internationally for decreasing smoking behaviour. Current warnings usually consist of a textual or graphic warning that smoking can result in adverse (well being) outcomes. Though these warnings have confirmed advantages, in addition they have vital limitations. Most notably, they don’t produce helpful adjustments in vital cognitive determinants of smoking cessation corresponding to self-efficacy to chorus from smoking and they don’t cut back smoking for particular subsets of the goal inhabitants.
Recent research present proof for the effectiveness of well being warnings that embrace health-related testimonies from former smokers. We designed cigarette pack warnings that consist of extra basic testimonial statements from former smokers, chosen in a pilot research for his or her potential influence on two vital cognitive determinants of smoking (i.e., self-efficacy beliefs and final result expectations). The Multidimensional Dyspnoea Profile is a respiratory questionnaire which makes an attempt to measure the incommunicable totally different sensory qualities (and emotional responses) of breathlessness.
In the principal research, on-line members had been both uncovered to the new testimonial warnings, to graphic well being warnings, or to text-only well being warnings on 4 separate events throughout a 24-h window. In a pattern of 416 each day smokers, we noticed helpful adjustments in self-reported cigarette smoking, craving, stop intentions, evaluations of smoking, self-efficacy, and final result expectations, instantly after viewing the warnings a primary time and after a number of exposures.
These results had been comparable for members in the three warning sort teams, with some (small) variations for adjustments in final result expectations and craving. Firearms accidents current a serious pediatric public well being problem in the United States. This research protocol describes analysis to develop and then conduct a randomized medical trial to judge ShootSafe, an interactive, participating, academic web site to show youngsters firearms security. Drawing on sensorial anthropology we take as our object of research the course of of turning sensations into signs. 
ShootSafe has three main targets: (a) train youngsters fundamental data and expertise wanted to hunt, shoot, and use firearms safely; (b) assist youngsters be taught and hone vital cognitive expertise of impulse management and hypothetical considering wanted to make use of firearms safely; and (c) alter youngsters’s perceptions about their very own vulnerability and susceptibility to firearms-related accidents, the severity of these accidents, and their perceived norms about peer conduct surrounding firearms use. ShootSafe will accomplish these targets by a mix of interactive video games plus quick, impactful testimonial movies and quick expert-led academic movies.

‘The physique says it’: the problem of measuring and speaking sensations of breathlessness

Breathlessness is a sensation affecting these residing with persistent respiratory illness, weight problems, coronary heart illness and anxiousness issues. We contemplate how shared cultural templates of ‘what counts as a symptom’ evolve, mediate and feed into the course of of bodily sensations changing into a symptom. Our contribution to the subject of sensorial anthropology, as an interdisciplinary collaboration between historical past, anthropology and the medical humanities, is to offer a critique of how biomedicine and cultures of medical analysis have measured the multidimensional sensorial points of breathlessness.
Using cognitive interviews of respiratory questionnaires with members from the Breathe Easy teams in the UK, we give examples of how the wording used to explain sensations is commonly at odds with the language these residing with breathlessness perceive or use. They wrestle to grasp and map their bodily expertise of sensations related with breathlessness to the phrases on the respiratory questionnaire. We mirror on the alignment between cognitive interviewing as a way and anthropology as a disciplinary method.
We argue biomedicine brings with it a set of cultural assumptions about what it means to measure (and know) the sensorial breathless physique in the context of the respiratory clinic (medical analysis). We recommend the mismatch between the descriptions (and confusion) of these responding to the respiratory questionnaire objects and these choosing the vocabularies in designing it might be symptomatic of a sort of historic testimonial epistemic injustice, based on the prioritisation of medical experience over experience by expertise.
Assessing the influence of warnings with testimonies from former smokers on smoking and quitting behaviour

A Blended Electronic Illness Management and Recovery Program for People With Severe Mental Illness: Qualitative Process Evaluation Alongside a Randomized Controlled Trial

We performed a trial to check the digital Illness Management and Recovery (e-IMR) intervention to offer conclusions on the potential efficacy of eHealth for individuals with extreme psychological sickness (SMI). In the e-IMR intervention, we used the customary IMR program content material and methodology and mixed face-to-face classes with internet-based methods on the constructed e-IMR web platform. During the trial, the e-IMR platform was sparsely used. This research aimed to judge the added worth of the e-IMR intervention and the boundaries and facilitators that may clarify the low use of the e-IMR platform.

Human Serine/Threonine Kinase 39 (STK39) ELISA Kit

RDR-STK39-Hu-48Tests 48 Tests
EUR 589

Human Serine/Threonine Kinase 39 (STK39) ELISA Kit

RDR-STK39-Hu-96Tests 96 Tests
EUR 820

STK39 Rabbit pAb

A7974-100ul 100 ul
EUR 308

STK39 Rabbit pAb

A7974-200ul 200 ul
EUR 459

STK39 Rabbit pAb

A7974-20ul 20 ul
EUR 183

STK39 Rabbit pAb

A7974-50ul 50 ul
EUR 223

Polyclonal STK39 / SPAK Antibody (Internal)

APR10306G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human STK39 / SPAK (Internal). This antibody is tested and proven to work in the following applications:

STK39 Antibody

1-CSB-PA237241
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

STK39 Antibody

CSB-PA245871-
EUR 335
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

STK39 Antibody

CSB-PA245871-100ul 100ul
EUR 316
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

STK39 Antibody

1-CSB-PA008878
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000

STK39 Antibody

1-CSB-PA008879
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000

STK39 Antibody

1-CSB-PA008880
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against STK39. Recognizes STK39 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000

Stk39 Antibody

24777-100ul 100ul
EUR 390

Stk39 Antibody

24781-100ul 100ul
EUR 390

STK39 Antibody

35079-100ul 100ul
EUR 252

STK39 Antibody

35079-50ul 50ul
EUR 187

STK39 Antibody

DF4548 200ul
EUR 304
Description: STK39 Antibody detects endogenous levels of total STK39.

STK39 Antibody

ABD4548 100 ug
EUR 438

STK39 antibody

10R-5982 100 ul
EUR 691
Description: Mouse monoclonal STK39 antibody

STK39 antibody

10R-5984 100 ul
EUR 691
Description: Mouse monoclonal STK39 antibody

STK39 antibody

70R-1017 100 ug
EUR 377
Description: Rabbit polyclonal STK39 antibody

Stk39 Antibody

4855-002mg 0.02 mg
EUR 171.82
Description: Stk39 Antibody: The serine/threonine kinase Stk39 belongs to the STE20 family, a group of kinases that are known to interact with inflammation-related kinases (such as p38, JNK, NKCC1, PKC-theta, WNK and MLCK), and with transcription factor AP-1. The STE 20 family is involved in diverse biological phenomena, including cell differentiation, cell transformation/ proliferation, cytoskeleton rearrangement, and the regulation of ion transporters. STK39 contains an N-terminal series of proline and alanine repeats (PAPA box), followed by a serine/threonine kinase catalytic domain and is abundantly expressed in the brain. STK39 is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled co-transporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. Recent studies show that STK39 tend to be a novel candidate gene for autism and hypertension.

Stk39 Antibody

4855-01mg 0.1 mg
EUR 436.42
Description: Stk39 Antibody: The serine/threonine kinase Stk39 belongs to the STE20 family, a group of kinases that are known to interact with inflammation-related kinases (such as p38, JNK, NKCC1, PKC-theta, WNK and MLCK), and with transcription factor AP-1. The STE 20 family is involved in diverse biological phenomena, including cell differentiation, cell transformation/ proliferation, cytoskeleton rearrangement, and the regulation of ion transporters. STK39 contains an N-terminal series of proline and alanine repeats (PAPA box), followed by a serine/threonine kinase catalytic domain and is abundantly expressed in the brain. STK39 is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled co-transporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. Recent studies show that STK39 tend to be a novel candidate gene for autism and hypertension.

Stk39 Antibody

4867-002mg 0.02 mg
EUR 171.82
Description: Stk39 Antibody: The serine/threonine kinase Stk39 belongs to the STE20 family, a group of kinases that are known to interact with inflammation-related kinases (such as p38, JNK, NKCC1, PKC-theta, WNK and MLCK), and with transcription factor AP-1. The STE 20 family is involved in diverse biological phenomena, including cell differentiation, cell transformation/ proliferation, cytoskeleton rearrangement, and the regulation of ion transporters. STK39 contains an N-terminal series of proline and alanine repeats (PAPA box), followed by a serine/threonine kinase catalytic domain and is abundantly expressed in the brain. STK39 is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled co-transporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. Recent studies show that STK39 tend to be a novel candidate gene for autism and hypertension.

Stk39 Antibody

4867-01mg 0.1 mg
EUR 436.42
Description: Stk39 Antibody: The serine/threonine kinase Stk39 belongs to the STE20 family, a group of kinases that are known to interact with inflammation-related kinases (such as p38, JNK, NKCC1, PKC-theta, WNK and MLCK), and with transcription factor AP-1. The STE 20 family is involved in diverse biological phenomena, including cell differentiation, cell transformation/ proliferation, cytoskeleton rearrangement, and the regulation of ion transporters. STK39 contains an N-terminal series of proline and alanine repeats (PAPA box), followed by a serine/threonine kinase catalytic domain and is abundantly expressed in the brain. STK39 is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled co-transporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. Recent studies show that STK39 tend to be a novel candidate gene for autism and hypertension.

STK39 antibody

70R-2693 50 ug
EUR 467
Description: Rabbit polyclonal STK39 antibody

STK39 antibody

70R-32739 100 ug
EUR 327
Description: Rabbit polyclonal STK39 antibody

STK39 antibody

70R-32741 100 ug
EUR 327
Description: Rabbit polyclonal STK39 antibody

Polyclonal Goat Anti-STK39 / SPAK Antibody

AMM05137G 0.1 mg
EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-STK39 / SPAK . This antibody is tested and proven to work in the following applications:

Polyclonal SPAK (STK39) Antibody (C-term)

APR10215G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SPAK (STK39) (C-term). This antibody is tested and proven to work in the following applications:

Polyclonal STK39 / SPAK Antibody (C-Terminus)

APR10305G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human STK39 / SPAK (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal Mouse Stk39 Antibody (C-term)

APR17451G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Mouse Stk39 (C-term). This antibody is tested and proven to work in the following applications:

STK39 (Phospho-Ser323) Polyclonal Conjugated Antibody

C11754 100ul
EUR 397

STK39 (Phospho-Ser309) Polyclonal Conjugated Antibody

C11755 100ul
EUR 397

Anti-STK39 antibody

STJ110281 100 µl
EUR 277
Description: This gene encodes a serine/threonine kinase that is thought to function in the cellular stress response pathway. The kinase is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress.

STK39 (pS325) Antibody

abx333100-100ul 100 ul
EUR 467

STK39 (pS311) Antibody

abx333246-100ul 100 ul
EUR 467

STK39 antibody (Ser325)

70R-32738 100 ug
EUR 327
Description: Rabbit polyclonal STK39 antibody (Ser325)

STK39 antibody (Ser311)

70R-32740 100 ug
EUR 327
Description: Rabbit polyclonal STK39 antibody (Ser311)

Stk39/ Rat Stk39 ELISA Kit

ELI-41620r 96 Tests
EUR 886

STK39 siRNA

20-abx935487
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

STK39 siRNA

20-abx935488
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

STK39 siRNA

20-abx905333
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

Stk39 Peptide

4855P 0.05 mg
EUR 164.75
Description: (CT) Stk39 peptide

Stk39 Peptide

4867P 0.05 mg
EUR 164.75
Description: (IN) Stk39 peptide

STK39 Peptide

42-014P 0.1 mg
EUR 338
Description: (IN) STK39 / SPAK Peptide

Phospho-STK39 (Ser325) Antibody

CSB-PA266675-
EUR 335
Description: A polyclonal antibody against Phospho-STK39 (Ser325). Recognizes Phospho-STK39 (Ser325) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

Phospho-STK39 (Ser325) Antibody

CSB-PA266675-100ul 100ul
EUR 362
Description: A polyclonal antibody against Phospho-STK39 (Ser325). Recognizes Phospho-STK39 (Ser325) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

Phospho-STK39 (S311) Antibody

1-CSB-PA008876
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Phospho-STK39 (S311). Recognizes Phospho-STK39 (S311) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

Phospho-STK39 (S325) Antibody

1-CSB-PA008877
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Phospho-STK39 (S325). Recognizes Phospho-STK39 (S325) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000

STK39 (Ab-311) Antibody

CSB-PA063933-
EUR 335
Description: A polyclonal antibody against STK39 (Ab-311). Recognizes STK39 (Ab-311) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

STK39 (Ab-311) Antibody

CSB-PA063933-100ul 100ul
EUR 316
Description: A polyclonal antibody against STK39 (Ab-311). Recognizes STK39 (Ab-311) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

Phospho-STK39 (Ser311) Antibody

CSB-PA029718-
EUR 335
Description: A polyclonal antibody against Phospho-STK39 (Ser311). Recognizes Phospho-STK39 (Ser311) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100

Phospho-STK39 (Ser311) Antibody

CSB-PA029718-100ul 100ul
EUR 362
Description: A polyclonal antibody against Phospho-STK39 (Ser311). Recognizes Phospho-STK39 (Ser311) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100

STK39 (Ab-325) Antibody

CSB-PA776395-
EUR 335
Description: A polyclonal antibody against STK39 (Ab-325). Recognizes STK39 (Ab-325) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

STK39 (Ab-325) Antibody

CSB-PA776395-100ul 100ul
EUR 316
Description: A polyclonal antibody against STK39 (Ab-325). Recognizes STK39 (Ab-325) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

STK39 (Phospho-Ser323) Antibody

11754-100ul 100ul
EUR 252

STK39 (Phospho-Ser323) Antibody

11754-50ul 50ul
EUR 187

STK39 (Phospho-Ser309) Antibody

11755-100ul 100ul
EUR 252

STK39 (Phospho-Ser309) Antibody

11755-50ul 50ul
EUR 187

STK39 (Ab-325) Antibody

33250-100ul 100ul
EUR 252

STK39 (Ab-325) Antibody

33250-50ul 50ul
EUR 187

STK39 (Ab-311) Antibody

33251-100ul 100ul
EUR 252

STK39 (Ab-311) Antibody

33251-50ul 50ul
EUR 187

STK39 (Phospho-Ser325) Antibody

20-abx012628
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

STK39 (Phospho-Ser311) Antibody

20-abx012629
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • EUR 70.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • 5 ug

Anti-STK39 / SPAK antibody

STJ71936 100 µg
EUR 359

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human)

4-PAN826Hu01
  • EUR 262.00
  • EUR 2747.00
  • EUR 679.00
  • EUR 331.00
  • EUR 220.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39)

STK39 Blocking Peptide

DF4548-BP 1mg
EUR 195

STK39 Blocking Peptide

33R-1647 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STK39 antibody, catalog no. 70R-2693

STK39 Blocking Peptide

33R-4741 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STK39 antibody, catalog no. 70R-1017

STK39 (Ab-311) Conjugated Antibody

C33251 100ul
EUR 397

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), APC

4-PAN826Hu01-APC
  • EUR 368.00
  • EUR 3599.00
  • EUR 993.00
  • EUR 472.00
  • EUR 229.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with APC.

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), Biotinylated

4-PAN826Hu01-Biotin
  • EUR 328.00
  • EUR 2697.00
  • EUR 786.00
  • EUR 404.00
  • EUR 226.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with Biotin.

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), Cy3

4-PAN826Hu01-Cy3
  • EUR 449.00
  • EUR 4757.00
  • EUR 1283.00
  • EUR 588.00
  • EUR 264.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with Cy3.

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), FITC

4-PAN826Hu01-FITC
  • EUR 314.00
  • EUR 2899.00
  • EUR 814.00
  • EUR 397.00
  • EUR 203.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with FITC.

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), HRP

4-PAN826Hu01-HRP
  • EUR 335.00
  • EUR 3135.00
  • EUR 877.00
  • EUR 426.00
  • EUR 215.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with HRP.

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), PE

4-PAN826Hu01-PE
  • EUR 314.00
  • EUR 2899.00
  • EUR 814.00
  • EUR 397.00
  • EUR 203.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with PE.

Rabbit Serine/Threonine Kinase 39 (STK39) ELISA Kit

abx362403-96tests 96 tests
EUR 825

Serine/Threonine Kinase 39 (STK39) Polyclonal Antibody (Human), APC-Cy7

4-PAN826Hu01-APC-Cy7
  • EUR 616.00
  • EUR 7078.00
  • EUR 1867.00
  • EUR 824.00
  • EUR 338.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Serine/Threonine Kinase 39 (STK39). This antibody is labeled with APC-Cy7.

Monoclonal STK39 Antibody(Ascites), Clone: 430CT4.4.1

APR10309G 0.1 ml
EUR 484
Description: A Monoclonal antibody against Human STK39(Ascites). The antibodies are raised in Mouse and are from clone 430CT4.4.1. This antibody is applicable in WB, E

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx129296
  • EUR 453.00
  • EUR 133.00
  • EUR 1316.00
  • EUR 620.00
  • EUR 342.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx123061
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx012938
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx012939
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Serine/Threonine Kinase 39 (STK39) Antibody

abx025397-100ul 100 ul
EUR 523

Serine/Threonine Kinase 39 (STK39) Antibody

abx025398-400ul 400 ul
EUR 523

Serine/Threonine Kinase 39 (STK39) Antibody

abx025398-80l 80 µl
EUR 286

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx014927
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Serine/Threonine Kinase 39 (STK39) Antibody

abx430426-200ul 200 ul
EUR 384

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx242387
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Serine/Threonine Kinase 39 (STK39) Antibody

20-abx174521
  • EUR 926.00
  • EUR 467.00
  • 1 mg
  • 200 ug

Serine/Threonine Kinase 39 (STK39) Antibody

abx331684-100ul 100 ul
EUR 425
This course of analysis was designed alongside a multicenter, cluster randomized managed trial. In this research, we included all accessible members and trainers from the intervention arm of the trial. Baseline traits had been used to match customers with nonusers. Qualitative knowledge had been gathered at the finish of the semistructured interviews. Using theoretical thematic analyses, the knowledge had been analyzed deductively utilizing a pre-existing coding body.  Out of 41 eligible members and 14 trainers, 27 members and 11 trainers had been interviewed.
Of the 27 members, 10 had beenrecognized as customers. eHealth parts that had added worthhad been the persuasive nature of the goal-tracking sheets, monitoring, and the peer testimonials, which had the potential to boost group discussions and disclosure by members. The low use of the e-IMR platform was influenced by the inflexibility of the platform, the lack of info know-how (IT) assets, the group context, members’ low laptop expertise and disabilities, and the hesitant eHealth angle of the trainers.